Cargando…

Evaluation of miR-362 Expression in Astrocytoma of Human Brain Tumors

BACKGROUND: Patients affected by gliomas have a poor prognosis. Astrocytoma is a subtype of glioma. Identification of biomarkers could be an effective way to an early diagnosis of tumor or to distinguish more aggressive tumors that need more intensive therapy. In this study, we investigated whether...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kheirollahi, Majid, Moodi, Mahdiye, Ashouri, Saeideh, Nikpour, Parvaneh, Kazemi, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5672651/ https://www.ncbi.nlm.nih.gov/pubmed/29142892 http://dx.doi.org/10.4103/2277-9175.216782

Ejemplares similares

Effect of teicoplanin on the expression of c-myc and c-fos proto-oncogenes in MCF-7 breast cancer cell line
por: Ashouri, Saeideh, et al.
Publicado: (2016)

Expression of ZFX gene correlated with the central features of the neoplastic phenotype in human brain tumors with distinct phenotypes
por: Afzali, Azita, et al.
Publicado: (2015)

The suppressive role of miR-362-3p in epithelial ovarian cancer
por: Yuan, Jialing, et al.
Publicado: (2020)

Existence of mutations in the homeodomain-encoding region of NKX2.5 gene in Iranian patients with tetralogy of Fallot
por: Kheirollahi, Majid, et al.
Publicado: (2016)

miR-362-3p suppresses ovarian cancer by inhibiting LRP8
por: Li, Chun, et al.
Publicado: (2021)

miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer
por: Cao, Shujun, et al.
Publicado: (2021)

MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma
por: Wang, Dan, et al.
Publicado: (2018)

Variant of SNP rs1317082 at CCSlnc362 (RP11-362K14.5) creates a binding site for miR-4658 and diminishes the susceptibility to CRC
por: Shen, Chaoqin, et al.
Publicado: (2018)

MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia
por: Ma, Qiu-Ling, et al.
Publicado: (2018)

Aberrant Expression of miR-362 Promotes Lung Cancer Metastasis through Downregulation of Sema3A
por: Luo, Dan, et al.
Publicado: (2018)

Aberrant miR-362-3p is Associated with EBV-Infection and Prognosis in Nasopharyngeal Carcinoma and Involved in Tumor Progression by Targeting JMJD2A
por: Wang, Xiangyun, et al.
Publicado: (2022)

Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma
por: Wu, Shuang, et al.
Publicado: (2022)

MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via down-regulation of GADD45α
por: Yang, Peng, et al.
Publicado: (2015)

Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells
por: Shu, Minfeng, et al.
Publicado: (2011)

Circular RNA MYLK promotes hepatocellular carcinoma progression by increasing Rab23 expression by sponging miR-362-3p
por: Li, Zhiqin, et al.
Publicado: (2019)

miR-362-5p promotes cell proliferation and cell cycle progression by targeting GAS7 in acute myeloid leukemia
por: Wu, Fuqun, et al.
Publicado: (2020)

MiR‐362 suppresses cervical cancer progression via directly targeting BAP31 and activating TGFβ/Smad pathway
por: Yang, Shuya, et al.
Publicado: (2020)

Retraction Note: MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via downregulation of GADD45α
por: Yang, Peng, et al.
Publicado: (2022)

Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p/MIOX axis as a ceRNA
por: Zhang, Ying, et al.
Publicado: (2022)

MicroRNA transcriptomes of distinct human NK cell populations identify miR-362-5p as an essential regulator of NK cell function
por: Ni, Fang, et al.
Publicado: (2015)

miR-101 reverses hypomethylation of the PRDM16 promoter to disrupt mitochondrial function in astrocytoma cells
por: Lei, Qianqian, et al.
Publicado: (2015)

CASC2c as an unfavorable prognosis factor interacts with miR-101 to mediate astrocytoma tumorigenesis
por: Liu, Changhong, et al.
Publicado: (2017)

Down Syndrome: Current Status, Challenges and Future Perspectives
por: Kazemi, Mohammad, et al.
Publicado: (2016)

MeDIP Real-Time qPCR has the Potential for Noninvasive Prenatal Screening of Fetal Trisomy 21
por: Kazemi, Mohammad, et al.
Publicado: (2017)

MiR-362-5p, Which Is Regulated by Long Non-Coding RNA MBNL1-AS1, Promotes the Cell Proliferation and Tumor Growth of Bladder Cancer by Targeting QKI
por: Wei, Xiaosong, et al.
Publicado: (2020)

Perillyl alcohol and quercetin modulate the expression of non-coding RNAs MIAT, H19, miR-29a, and miR-33a in pulmonary artery hypertension in rats
por: Rajabi, Soodeh, et al.
Publicado: (2022)

Intestinal Expression of miR-130b, miR-410b, and miR-98a in Experimental Canine Echinococcosis by Stem-Loop RT-qPCR
por: Faridi, Ashkan, et al.
Publicado: (2020)

Expression of miR-127, miR-154, and miR-183 in Medullary Thyroid Carcinoma Tumors
por: RAHMANI SAMANI, Mahsa, et al.
Publicado: (2021)

Aberrant Expression of miR-103, miR-184, miR-378, miR-497 and miR-506 in Tumor Tissue from Patients with Oral Squamous Cell Carcinoma Regulates the Clinical Picture of the Patients
por: Ghaffari, Maryam, et al.
Publicado: (2020)

miR-106a-5p Inhibits the Proliferation and Migration of Astrocytoma Cells and Promotes Apoptosis by Targeting FASTK
por: Zhi, Feng, et al.
Publicado: (2013)

SNHG17 drives malignant behaviors in astrocytoma by targeting miR-876-5p/ERLIN2 axis
por: Du, Fengping, et al.
Publicado: (2020)

Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients
por: Hallal, Susannah, et al.
Publicado: (2020)

Brain tumors: Special characters for research and banking
por: Kheirollahi, Majid, et al.
Publicado: (2015)

SP1/AKT/FOXO3 Signaling Is Involved in miR-362-3p-Mediated Inhibition of Cell-Cycle Pathway and EMT Progression in Renal Cell Carcinoma
por: Zhu, Hejia, et al.
Publicado: (2020)

Aberrant Expression of Breast Development-Related MicroRNAs, miR-22, miR-132, and miR-212, in Breast Tumor Tissues
por: Damavandi, Zahra, et al.
Publicado: (2016)

Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma
por: Nakka, Manjula, et al.
Publicado: (2017)

Differential expression of miR-1297, miR-3191-5p, miR-4435, and miR-4465 in malignant and benign breast tumors
por: Mosapour, Abbas, et al.
Publicado: (2020)

The Oncogenic Relevance of miR-17-92 Cluster and Its Paralogous miR-106b-25 and miR-106a-363 Clusters in Brain Tumors
por: Gruszka, Renata, et al.
Publicado: (2018)

Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer
por: Larki, Pegah, et al.
Publicado: (2018)

MiR‐92b and miR‐9/9* Are Specifically Expressed in Brain Primary Tumors and Can Be Used to Differentiate Primary from Metastatic Brain Tumors
por: Nass, Dvora, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_6dos1fkg7hm221k4or5m04km9l